Page last updated: 2024-08-24

3-iodobenzylguanidine and Psychoses

3-iodobenzylguanidine has been researched along with Psychoses in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akiyama, N; Kobayashi, K; Maeda, T; Nakano, H; Yamamori, S1
Akiyama, N; Kobayashi, K; Koshino, Y; Nakano, H; Sumiya, H; Urata, K1

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and Psychoses

ArticleYear
Pure psychiatric presentation of the Lewy body disease is depression--an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study.
    International journal of geriatric psychiatry, 2015, Volume: 30, Issue:6

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Biomarkers; Depressive Disorder; Female; Hallucinations; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardium; Parkinson Disease; Psychotic Disorders; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2015
Detection of Lewy body disease in patients with late-onset depression, anxiety and psychotic disorder with myocardial meta-iodobenzylguanidine scintigraphy.
    International journal of geriatric psychiatry, 2010, Volume: 25, Issue:1

    Topics: 3-Iodobenzylguanidine; Age of Onset; Aged; Aged, 80 and over; Anxiety Disorders; Cognition Disorders; Depressive Disorder; Female; Hallucinations; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Psychotic Disorders; Radiopharmaceuticals

2010